Results 41 to 50 of about 206,019 (383)

Isolated hemolytic anemia: an unusual manifestation of occult malignancy

open access: yesHematology Reports, 2014
Hemolysis is an uncommon and usually late complication of malignancy, and very rarely the presenting feature. Cancer-associated hemolysis may be immune-mediated, or may result from thrombotic microangiopathy accompanied by thrombocytopenia.
Matthew J. Butler, Ming Yin, Fahd Quddus
doaj   +1 more source

Bell Shape Curves of Hemolysis Induced by Silver Nanoparticles: Review and Experimental Assay

open access: yesNanomaterials, 2022
The hemolytic activity assay is a versatile tool for fast primary toxicity studies. This work presents a systematic study of the hemolytic properties of ArgovitTM silver nanoparticles (AgNPs) extensively studied for biomedical applications.
Roberto Luna-Vázquez-Gómez   +9 more
doaj   +1 more source

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study) [PDF]

open access: yes, 2013
This prospective, multicenter, single-arm, open-label Phase III study aimed to evaluate the efficacy and safety of Privigen (R) (10% liquid human intravenous immunoglobulin [IVIG], stabilized with l-proline) in patients with chronic inflammatory ...
Bauhofer, Artur   +12 more
core   +1 more source

P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2019
Significance Complement system activation occurs in sickle cell disease and other hemolytic disorders, but the pathological relevance and the acquisition of a complement-activating phenotype by host cells during hemolysis remain unclear.
N. Merle   +9 more
semanticscholar   +1 more source

Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. [PDF]

open access: yes, 2013
Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects.
Bratt, Jennifer M   +6 more
core   +5 more sources

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens. [PDF]

open access: yes, 2017
The fast development of multi-drug resistant (MDR) organisms increasingly threatens global health and well-being. Plant natural products have been known for centuries as alternative medicines that can possess pharmacological characteristics, including ...
Alsaadi, Abrar I   +6 more
core   +2 more sources

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria

open access: yesEmerging Infectious Diseases, 2016
Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunate have been described. We performed a prospective observational study of patients with uncomplicated malaria to investigate whether posttreatment ...
Florian Kurth   +14 more
doaj   +1 more source

Clinical relevance of silent red blood cell autoantibodies. [PDF]

open access: yes, 2017
.
Alessandri, C   +14 more
core   +1 more source

Complement in Hemolysis- and Thrombosis- Related Diseases

open access: yesFrontiers in Immunology, 2020
The complement system, originally classified as part of innate immunity, is a tightly self-regulated system consisting of liquid phase, cell surface, and intracellular proteins.
Shanshan Luo   +4 more
semanticscholar   +1 more source

Analysis on Evaluation Method of Mechanically-Induced Hemolysis of Medical Devices

open access: yesZhongguo yiliao qixie zazhi
Mechanically-induced hemolysis is an important index for evaluating the blood compatibility of medical devices. It mainly evaluates the risk of mechanical hemolysis under simulated clinical use conditions of medical devices.
Jianxiu ZHU, Zhichen ZHAI
doaj   +1 more source

Home - About - Disclaimer - Privacy